Dasabuvir (ABT-333)

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
10 mg	In-stock	$150.00	Visible after login	- +
25 mg	In-stock	$245.00	Visible after login	- +
50 mg	In-stock	$392.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

10 mg

In-stock

$150.00

Visible after login

- +

25 mg

In-stock

$245.00

Visible after login

- +

50 mg

In-stock

$392.00

Visible after login

- +

Product Overview

Product Name	Dasabuvir \| ABT-333
CAS	1132935-63-7
Formula	C26H27N3O5S
MW	493.57
Appearance	White to yellow powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Dasabuvir (formerly known as ABT-333; ABT333; trade name Exviera, Viekira Pak, Viekira XR) is a nonnucleoside inhibitor of the RNA-dependent RNA polymerase encoded by the hepatitis C virus (HCV) NS5B gene. It inhibited recombinant NS5B polymerases derived from HCV genotype 1a and 1b clinical isolates, with IC50 values between 2.2 and 10.7 nM, and was at least 7,000-fold selective for the inhibition of HCV genotype 1 polymerases over human/mammalian polymerases. Dasabuvir is an FDA approved antiviral medication for the treatment of hepatitis C. It is often used together with the combination medication ombitasvir/paritaprevir/ritonavir specifically for hepatitis C virus (HCV) type 1.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History